Home | Welcome to Contract Pharma   
Last Updated Thursday, November 27 2014
Print

Search Results for 'Cook Pharmica Gains New FDA Approval'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Taking a Proactive Approach to Patient Safety Monitoring
By Dr. Chitra Lele , Chief Scientific Officer, Sciformix Corporation
Published September 8, 2014
Stringent pharmacovigilance standards are needed during drug development and post-approval stages. Read More »
Published April 24, 2014
Employs Novozymes' VELTIS technology for optimized dosing Read More »
Biosimilars Update
By Gil Roth, Contract Pharma
Published April 3, 2013
When will we see legal generics of top biopharmaceuticals? Read More »
Published March 25, 2013
Similar to Changes Being Effected (CBE). A filing with the FDA to gain approval of a moderate change, i.e., a change that has a moderate potential to have an adverse effect on the identity, strength, quality, purity, or potency of the drug product as… Read More »
By Gil Roth
Published March 25, 2013
PAI waived, Cook Pharmica to help reduce drug shortage Read More »
Biosimilar Outsourcing Update
By Gil Roth, Contract Pharma
Published May 4, 2012
FDA’s draft guidance leads to new opportunities Read More »
Assuring Quality in the Global Supply Chain
By Helena Champion
Published September 3, 2009
Measuring risk in sourcing Read More »
Quality Assurance and Good Lab Practice
By Paul Swidersky
Published May 2, 2007
Examining the FDAs and OECDs GLPs Read More »
By Gil Y. Roth
Published August 22, 2005
Will a building boom solve the capacity crunch? Read More »
Preclinical Outsourcing Report
By Jay Mehta
Published September 7, 2011
Long-term and more collaborative contracts to optimize cost structures Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On